8 studies found for:    17960013 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Induction Chemotherapy With GP Versus TPF in the Treatment of Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: A combination of Gemcitabine and cisplatin;   Drug: A combination of Docetaxel, cisplatin and 5-Fluorouracil
2 Terminated Study of Chemotherapy Prior to Radiotherapy and Chemotherapy in Patients With HPV Associated Cancer of the Oral Cavity
Condition: Oropharyngeal Neoplasms
Interventions: Drug: chemotherapy;   Radiation: radiotherapy;   Radiation: Reduced dose radiotherapy
3 Unknown  Cabazitaxel - PF Induction Chemotherapy
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Cabazitaxel 10mg/m2;   Drug: Cabazitaxel 12.5mg/m2;   Drug: Experimental: Cabazitaxel 15mg/m2;   Drug: Experimental: Cabazitaxel 17.5mg/m2;   Drug: Cabazitaxel 20mg/m2
4 Active, not recruiting Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Docetaxel, cisplatin and fluorouracil;   Radiation: Concurrent chemoradiotherapy
5 Recruiting Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC)
Condition: Nasopharyngeal Carcinoma
Intervention: Drug: Docetaxel, Cisplatin, 5-FU and Cetuximab
6 Not yet recruiting The Value of Single-cycle TPF Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: One cycle TPF induction chemotherapy for NPC;   Drug: Three cycles TPF induction chemotherapy for NPC
7 Unknown  InductionChemo-Radio-Antibody-Treatment
Conditions: Squamous Cell Carcinoma of the Head;   Squamous Cell Carcinoma of the Neck
Interventions: Drug: TPF induction chemotherapy;   Drug: TPF experimental;   Radiation: Standard Radiochemotherapy (HART)
8 Completed Induction Chemotherapy Comparing Taxotere® Cisplatin and 5-Fluorouracil (TPF) With Standard Cisplatin and 5-Fluorouracil (PF) Followed by Chemoradiation in Locally Advanced Head and Neck Cancer
Condition: Cancer
Intervention: Drug: XRP6976 (Docetaxel/Taxotere)

Indicates status has not been verified in more than two years